...a series A round led by Schusterman Family Investments, Duquesne Family Office, Catalio Capital Management and Dexcel Pharma...

...I diabetes; and one from NIH: KT-A522 for Type II diabetes and obesity. QVT and Dexcel Pharma...
...Corporate partners: N/A Number of employees: 8 Funds raised: More than $80.5 million Investors: QVT, Dexcel Pharma...

...corporate development lead. After raising $1.1 billion in equity financing from SoftBank Vision Fund and Dexcel Pharma...

...corporate development lead. After raising $1.1 billion in equity financing from SoftBank Vision Fund and Dexcel Pharma...

...Roivant raised $1.1 billion in an equity financing led by SoftBank Vision Fund. Existing investor Dexcel Pharma...
...founder and CEO Vivek Ramaswamy, Roivant raised $90 million in May 2014 from QVT Fund, Dexcel Pharma...

...Switzerland) raised $1.1 billion in an equity financing led by SoftBank Vision Fund. Existing investor Dexcel Pharma...

...Switzerland) raised $1.1 billion in an equity financing led by SoftBank Vision Fund. Existing investor Dexcel Pharma...

...Advisors; Aisling Capital ; Venrock; Broadfin Capital; Sphera Global Healthcare Fund; DAFNA Capital Management LLC; Dexcel Pharma WIR...

...after offering: 78.6 million Placement agents: M Partners; Noble Financial Capital Markets Investors: Institutional investors; Dexcel Pharma...
...comprises a share and a five-year warrant to purchase a share at C$0.81. Existing investor Dexcel Pharma...

...Inc. (TSX:CTH), Toronto, Ontario Business: Drug delivery, Neurology Appointed: Tomer Gold, VP of R&D at Dexcel Pharma...